Immunovant Inc.
IMVT | NASDAQ
$37.12
-$0.06 (-0.16%)
Sep 22, 2026, 10:23 AM ET · Market open
Fiscal Year Period Ending | FY 2026 Mar 30, 2026 | FY 2025 Mar 30, 2025 | FY 2024 Mar 30, 2024 | FY 2023 Mar 30, 2023 | FY 2022 Mar 30, 2022 | FY 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|
PE Ratio | -8.97 | -6.26 | -16.81 | -9.07 | -3.85 | -13.15 |
PEG Ratio | -6.12 | -0.14 | -1.69 | -0.46 | -0.22 | 0.63 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 5.31 | 3.66 | 7.07 | 5.27 | 1.29 | 3.60 |
P/FCF Ratio | -11.12 | -6.88 | -20.34 | -10.13 | -5.68 | -16.85 |
P/OCF Ratio | -11.13 | -6.89 | -20.38 | -10.14 | -5.70 | -16.89 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0 | 0 | 0 | 0 | 0.01 | 0.01 |
Quick Ratio | 9.09 | 11.16 | 13.70 | 9.34 | 11.52 | 21.79 |
Current Ratio | 9.09 | 11.16 | 13.70 | 9.34 | 11.52 | 21.79 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | -16.69 | n/a | n/a |
Return on Equity | -59.30% | -58.50% | -41.98% | -58.20% | -33.36% | -27.44% |
Return on Assets | -52.80% | -53.31% | -38.90% | -51.98% | -30.40% | -26.04% |
Return on Invested Capital | -62.46% | -61.93% | -43.71% | -57.26% | -33.03% | -27.29% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove IMVT